[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 26, 1994

More Conflicts of Interest: Review Articles Sponsored by the Pharmaceutical Industry

Author Affiliations

Ohio State University Columbus

JAMA. 1994;272(16):1253. doi:10.1001/jama.1994.03520160037031
Abstract

To the Editor.  —The recent article by Dr Witt and Mr Gostin1 was interesting and informative. One subject missing from the article was payment of honoraria by the pharmaceutical industry to established investigators for publishing review articles. Some pharmaceutical companies may offer assistance in searching literature and writing a draft of the article either directly or through a contracted service. Even if the investigator writes the entire article, it is expected that the pharmaceutical company would review it and provide comments or suggestions for revision prior to its submission to a journal.This may give the pharmaceutical company an opportunity to include data on file and, more importantly, present its product most effectively in relation to competitive products since other companies would not have the same opportunity. Interestingly, the receipt of honoraria for review articles is rarely disclosed. Such disclosures to their readers should be required by all journals.

First Page Preview View Large
First page PDF preview
First page PDF preview
×